Cindy N.
- Country
- France
- Department
- Oncology
Research Overview
- A Phase I/II Study of KISIMA-02 Vaccine-Based Immunotherapy in KRAS G12D/G12V Mutated Pancreatic Ductal Adenocarcinoma Patients
- Phase 1b/2 Study of S095029 and Pembrolizumab in MSI-H/dMMR Gastroesophageal Junction and Gastric Cancer
- Phase III Randomized Double-Blind Study of Rilvegostomig Plus Chemotherapy in Adjuvant Treatment of Resected Biliary Tract Adenocarcinoma
Data & Insights
Has run more than one trial at 37 of 122 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating esophageal carcinoma and gastric cancer, with particular focus on advanced disease states. Their research encompasses both localized and metastatic conditions, including specific interest in PD-L1 expressing tumors.
- Esophageal cancer treatment modalities
- Gastric adenocarcinoma management
- Microbiome-based therapeutic approaches
Hepatobiliary Oncology
The investigator focuses on biliary tract cancers, including both intrahepatic and extrahepatic manifestations. Their expertise extends to personalized treatment approaches for advanced biliary cancer and innovative therapeutic strategies.
- Cholangiocarcinoma treatment
- Gallbladder cancer management
- Targeted therapy applications
Pancreatic Cancer Research
The investigator concentrates on treating pancreatic ductal adenocarcinoma, with particular emphasis on innovative approaches for both locally advanced and metastatic disease. Their work includes investigation of mutation-specific therapies and immunotherapeutic strategies.
- KRAS-mutated pancreatic cancer
- Maintenance therapy strategies
- Vaccine-based immunotherapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.